Prediction Case File
YouTubeTracking Live

Friends! In this video, I will conduct an S&P Global stock analysis and discuss the risks and upside potential of SPGI stock.

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
12 Feb 2026, 00:06 UTC
Recorded by Tahlil Plus
18 May 2026, 20:24 UTC
Video preview for Friends! In this video, I will conduct an S&P Global stock analysis and discuss the risks and upside potential of SPGI stock.
Source overview

AI-generated source summary

The analysis focuses on S&P Global (SPGI) and its segments, highlighting the potential impact of AI on its market intelligence and ESG rating businesses. The stock is currently trading at a PE ratio of 20, with a forward PE of 16.2. The presenter uses a discounted cash flow model, estimating a 2-year forward PE of 26, suggesting an upside potential of 107% and a 16.19% annual return. However, in a more conservative scenario with no PE expansion and a 20x multiple, the stock is considered undervalued at $327, representing a potential downside of -18.46%. The MSCI index is also mentioned as a comparable asset.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.6
Tracked signals
324
Historical success
34.4%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail